19933077

Source:http://linkedlifedata.com/resource/pubmed/id/19933077

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0030705, umls-concept:C0035647, umls-concept:C0153690, umls-concept:C0392756, umls-concept:C1257954, umls-concept:C2757001
pubmed:issue	4
pubmed:dateCreated	2009-11-25
pubmed:abstractText	We hypothesize that the use of cyclooxygenase (COX)-2 inhibitors in early disease phases could protect against the development of bony metastases.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100898731
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1938-0666
pubmed:author	pubmed-author:JaslowRebeccaR, pubmed-author:PomerantzSherry CSC, pubmed-author:TesterWilliamW, pubmed-author:ValsecchiMatias EME
pubmed:issnType	Electronic
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	225-30
pubmed:meshHeading	pubmed-meshheading:19933077-Aged, pubmed-meshheading:19933077-Bone Neoplasms, pubmed-meshheading:19933077-Breast Neoplasms, pubmed-meshheading:19933077-Cyclooxygenase 2 Inhibitors, pubmed-meshheading:19933077-Female, pubmed-meshheading:19933077-Humans, pubmed-meshheading:19933077-Middle Aged, pubmed-meshheading:19933077-Neoplasm Staging, pubmed-meshheading:19933077-Risk Factors, pubmed-meshheading:19933077-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Reduced risk of bone metastasis for patients with breast cancer who use COX-2 inhibitors.
pubmed:affiliation	Department of Medicine, Albert Einstein Medical Center, Philadelphia, PA 19141, USA. valseccm@einstein.edu
pubmed:publicationType	Journal Article, Comparative Study